State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes

  • Bozdag M
  • Altamimi A
  • Vullo D
  • et al.
19Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2019 Bentham Science Publishers. The current review is intended to highlight recent advances in the search of new and effective modulators of the metalloenzymes Carbonic Anhydrases (CAs, EC 4.2.1.1) expressed in humans (h). CAs reversibly catalyze the CO2 hydration reaction, which is of crucial importance in the regulation of a plethora of fundamental processes at cellular level as well as in complex organisms. The first section of this review will be dedicated to compounds acting as activators of the hCAs (CAAs) and their promising effects on central nervous system affecting pathologies mainly characterized from memory and learning impairments. The second part will focus on the emerging chemical classes acting as hCA inhibitors (CAIs) and their potential use for the treatment of diseases.

Cite

CITATION STYLE

APA

Bozdag, M., Altamimi, A. S. A., Vullo, D., Supuran, C. T., & Carta, F. (2018). State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes. Current Medicinal Chemistry, 26(15), 2558–2573. https://doi.org/10.2174/0929867325666180622120625

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free